KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ginkgo Bioworks Holdings (DNA) Cash from Financing Activities (2020 - 2025)

Historic Cash from Financing Activities for Ginkgo Bioworks Holdings (DNA) over the last 6 years, with Q3 2025 value amounting to $9.9 million.

  • Ginkgo Bioworks Holdings' Cash from Financing Activities rose 223720.43% to $9.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.4 million, marking a year-over-year increase of 53496.31%. This contributed to the annual value of -$1.7 million for FY2024, which is 4592.66% up from last year.
  • As of Q3 2025, Ginkgo Bioworks Holdings' Cash from Financing Activities stood at $9.9 million, which was up 223720.43% from -$98000.0 recorded in Q2 2025.
  • Over the past 5 years, Ginkgo Bioworks Holdings' Cash from Financing Activities peaked at $1.5 billion during Q3 2021, and registered a low of -$11.0 million during Q4 2021.
  • For the 5-year period, Ginkgo Bioworks Holdings' Cash from Financing Activities averaged around $86.0 million, with its median value being -$433000.0 (2021).
  • Its Cash from Financing Activities has fluctuated over the past 5 years, first crashed by 583709.68% in 2021, then skyrocketed by 223720.43% in 2025.
  • Ginkgo Bioworks Holdings' Cash from Financing Activities (Quarter) stood at -$11.0 million in 2021, then skyrocketed by 985.29% to $97.8 million in 2022, then crashed by 100.65% to -$632000.0 in 2023, then skyrocketed by 67.88% to -$203000.0 in 2024, then soared by 4995.57% to $9.9 million in 2025.
  • Its Cash from Financing Activities stands at $9.9 million for Q3 2025, versus -$98000.0 for Q2 2025 and -$207000.0 for Q1 2025.